Locations
Durham, NC, USA
industry
Biotechnology · DeepTech · Health
Size
51-200 employees
Stage
Series A
founded in
2019
Xilis is a biotechnology company that develops technologies to guide precision therapy for cancer patients and accelerate drug discovery. The company's platform enables diagnostics, drug screening, and scalable patient-derived models for drug discovery, enabling physicians and pharmaceutical companies to develop tailored treatments for patients by conducting drug screening.
Something looks off?